In the case of a nulligravid woman, which lab test is good for predicting the risk of developing preeclampsia?

In the case of a nulligravid woman, the anticardiolipin antibody test is significant for predicting the risk of developing preeclampsia. This antibody is part of a group of antibodies associated with antiphospholipid syndrome, which has been linked to an increased risk of various pregnancy complications, including preeclampsia. Elevated levels of anticardiolipin antibodies can indicate an increased risk for the mother to develop not only preeclampsia but also other issues related to placental function.

Monitoring for these antibodies may help physicians identify women who are at a higher risk for complications during pregnancy, allowing for closer surveillance and management strategies to mitigate adverse outcomes. While the other lab tests listed have their own importance in different contexts, they are not specifically validated for predicting preeclampsia risk in a nulligravid woman as anticardiolipin antibodies are.